APG Asset Management N.V. Buys 22,289 Shares of Agilent Technologies, Inc. (NYSE:A)

APG Asset Management N.V. lifted its position in Agilent Technologies, Inc. (NYSE:A) by 13.1% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 192,192 shares of the medical research company’s stock after purchasing an additional 22,289 shares during the quarter. APG Asset Management N.V. owned 0.07% of Agilent Technologies worth $23,246,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in A. Livelsberger Financial Advisory bought a new position in Agilent Technologies in the 4th quarter valued at $26,000. Crewe Advisors LLC increased its stake in shares of Agilent Technologies by 114.8% in the second quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock valued at $25,000 after buying an additional 101 shares in the last quarter. Ridgewood Investments LLC bought a new position in shares of Agilent Technologies in the second quarter valued at about $29,000. Rise Advisors LLC lifted its position in Agilent Technologies by 527.8% during the 1st quarter. Rise Advisors LLC now owns 226 shares of the medical research company’s stock worth $33,000 after buying an additional 190 shares in the last quarter. Finally, YHB Investment Advisors Inc. bought a new stake in Agilent Technologies during the 1st quarter worth about $34,000. Institutional investors and hedge funds own 87.42% of the company’s stock.

Analyst Upgrades and Downgrades

A has been the subject of several research reports. UBS Group lifted their target price on Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a research note on Thursday, August 22nd. Wells Fargo & Company initiated coverage on shares of Agilent Technologies in a research report on Tuesday, August 27th. They set an “overweight” rating and a $157.00 target price on the stock. Wolfe Research cut shares of Agilent Technologies from an “outperform” rating to a “peer perform” rating in a research report on Thursday, June 27th. Evercore ISI increased their price objective on shares of Agilent Technologies from $130.00 to $135.00 and gave the company an “in-line” rating in a report on Thursday, August 22nd. Finally, Jefferies Financial Group reaffirmed a “hold” rating and set a $135.00 target price (down previously from $152.00) on shares of Agilent Technologies in a report on Monday, June 3rd. One analyst has rated the stock with a sell rating, five have assigned a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $142.93.

Agilent Technologies Trading Up 0.9 %

NYSE:A opened at $148.06 on Friday. The company has a market cap of $43.20 billion, a P/E ratio of 35.00, a price-to-earnings-growth ratio of 6.48 and a beta of 1.05. Agilent Technologies, Inc. has a twelve month low of $96.80 and a twelve month high of $155.35. The business has a 50 day moving average price of $138.91 and a two-hundred day moving average price of $139.05. The company has a quick ratio of 1.37, a current ratio of 1.78 and a debt-to-equity ratio of 0.36.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, August 21st. The medical research company reported $1.32 EPS for the quarter, topping analysts’ consensus estimates of $1.26 by $0.06. The company had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.56 billion. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. The company’s quarterly revenue was down 5.6% on a year-over-year basis. During the same period in the prior year, the business posted $1.43 EPS. As a group, analysts expect that Agilent Technologies, Inc. will post 5.24 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 23rd. Stockholders of record on Tuesday, October 1st will be given a $0.236 dividend. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.64%. The ex-dividend date is Tuesday, October 1st. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.22%.

Insider Transactions at Agilent Technologies

In other news, SVP Dominique Grau sold 9,990 shares of the stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $145.00, for a total value of $1,448,550.00. Following the transaction, the senior vice president now directly owns 40,011 shares of the company’s stock, valued at $5,801,595. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other Agilent Technologies news, SVP Dominique Grau sold 9,990 shares of the business’s stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the transaction, the senior vice president now directly owns 40,011 shares in the company, valued at $5,801,595. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Padraig Mcdonnell sold 1,958 shares of the firm’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total value of $283,910.00. Following the completion of the sale, the chief executive officer now directly owns 24,118 shares in the company, valued at approximately $3,497,110. The disclosure for this sale can be found here. Insiders have sold 13,906 shares of company stock worth $2,006,580 in the last ninety days. Insiders own 0.33% of the company’s stock.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.